基于风险分层看甲状腺微小乳头状癌的合理管理  

Optimal management of papillary thyroid microcarcinoma based on risk stratification

作　　者：任虞洁 徐书杭[1] Ren Yujie;Xu Shuhang(Department of Endocrinology and Metabolism,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210028,China)

机构地区：[1]南京中医药大学附属中西医结合医院内分泌科,南京210028

出　　处：《国际内分泌代谢杂志》2025年第1期23-26,共4页International Journal of Endocrinology and Metabolism

基　　金：2020年江苏省重点研发计划(BE2020726);江苏省卫生健康委医学科研项目(面上项目)(M2020102);中华国际医学交流基金会甲状腺中青年医生研究项目(BQE-JZX-202115)。

摘　　要：由于医疗保险系统的完善及诊断技术的广泛应用,甲状腺癌的患病率逐年上升,其中绝大多数为预后良好的甲状腺微小乳头状癌(PTMC)。同时,甲状腺癌的死亡率保持相对较低和稳定。因此,当前的筛查与诊断可能更多地造成了PTMC的过度诊断。手术是PTMC首选治疗方式,但目前已有许多研究表明积极观察和热消融也是治疗低危PTMC的有效方法。当前,应基于肿瘤的术前特征进行PTMC的风险分层,并依据不同风险制定合理的管理策略。Due to the improvement of the medical insurance system and the wide application of diagnostic technology,the prevalence of thyroid cancer is increasing year by year,and most of them are papillary thyroid microcarcinoma(PTMC)which have a favorable prognosis.Meanwhile,the mortality rate of thyroid cancer remains relatively low and stable.Therefore,the current screening and diagnosis are believed to have caused the overdiagnosis of PTMC.Surgical treatment remains the first choice for PTMC,while many studies have shown that active surveillance and thermal ablation are also effective in treating low-risk PTMC.At present,the risk of PTMC should be stratified based on preoperative characteristics and thus manage the PTMC properly according to different risks.

关 键 词：甲状腺微小乳头状癌 诊断 热消融 治疗 

分 类 号：R73[医药卫生—肿瘤]